SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
2.960
-0.150 (-4.82%)
May 16, 2025, 4:00 PM - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $197.79 million as of May 19, 2025. Its market cap has decreased by -39.90% in one year.
Market Cap
197.79M
Enterprise Value
159.39M
1-Year Change
-39.90%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $197.79M, a decrease of -82.35%. That is a compound annual growth rate of -36.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 197.79M | -3.03% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |